FindTrial
Sign In

Dacryoendoscopic dacryocystoethmoidostomy for the treatment of nasolacrimal duct obstruction

Dacryoendoscopic dacryocystoethmoidostomy for the treatment of nasolacrimal duct obstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067804
Enrollment
Unknown
Registered
2023-01-28
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasolacrimal duct obstruction

Interventions

Test group:Surgery

Sponsors

Tianjin Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patients with nasolacrimal duct obstruction.

Exclusion criteria

Exclusion criteria: 1. The patients with ethmoidal sinus disease; 2. The patients with severe systemic diseases.

Design outcomes

Primary

MeasureTime frame
Irrigation of lacrimal passage;—

Countries

China

Contacts

Public ContactZhao Hong

Tianjin Eye Hospital

liqingji@sina.com+86 15022775028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026